mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-06 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |